Cytokinetics, Incorporated (CYTK) vs Praxis Precision Medicines, Inc. (PRAX)
Cytokinetics, Incorporated and Praxis Precision Medicines, Inc. are both Biotechnology companies. Cytokinetics, Incorporated is the larger, with a market value of $9.0B against $7.9B — 1.1× the size. Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against −21.1%. Praxis Precision Medicines, Inc. has the higher net margin (0.00% vs −1,321.1%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 16 metrics below, Praxis Precision Medicines, Inc. leads on 9 and Cytokinetics, Incorporated on 7.
Valuation
Profitability
| Metric | CYTK | PRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.97% | 100.00% | 65.16% |
| Operating margin | (1,046.12%) | 0.00% | 0.00% |
| Net margin | (1,321.12%) | 0.00% | 0.00% |
| Free cash flow margin | (858.16%) | 0.00% | 0.00% |
| Return on equity | 329.76% | (38.86%) | (57.72%) |
| Return on assets | (56.76%) | (36.80%) | (49.22%) |
| Return on invested capital | 0.00% | (40.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack